About Acomplia Diet Pills - generic RimonabantAcomplia is all set to surprise the weight loss drug market. Acomplia has dual advantage attached to it property since it can help people both lose weight and quit smoking.

Acomplia (generic Rimonabant) works by blocking the CB-1 receptors that governs food intake and tobacco dependency. These receptors that are blocked by Acomplia are in the brain, and also throughout the body, notably in fat cells. Among other things, the CB-1 receptors blocked by Rimonabant account for the sudden surge of appetite felt by people who smoke marijuana. Doctors say that this system of receptors, CB-1, is disrupted by tobacco and by chronic overeating.

Acomplia restores the balance in the CB-1 receptors system, reducing dependence on tobacco and suppressing appetite. Since many smokers are also overweight, Rimonabant diet pills could end up doing double duty.

A new anti-obesity pill that has been shown to not only help lose weight and quit smoking could also be effective in helping people stop drug and alcohol addiction, scientists claim.

Acomplia, or rimonabant, is an experimental drug developed by the French pharmaceutical firm Sanofi-Aventis primarily as a diet pill, but the drug works differently that most diet pills in that it blocks the brain’s reward system.

It works by blocking the connection between a pleasure-seeking activity, like smoking or overeating, and the reward “feeling” it causes in the brain. The human body contains endocannabinoids, marijuana-like substances that can stimulate the brain’s reward system.

Acomplia blocks the effect of the natural endocannabinoids by keeping them from attaching to the brain cells they usually stimulate, scientists say.

In March of this year, Acomplia gained a great deal of attention when two research studies demonstrated that it could not only help people lose weight, but quit smoking

 

Leave a comment

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <blockquote cite=""> <code> <em> <strong>